Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)
Status:
Completed
Trial end date:
2018-06-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics and safety
after single oral administration of FYU-981 to subjects with hepatic insufficiency and with
normal hepatic function.